Smoking and smoking cessation in relation to all-cause mortality and cardiovascular events in 25,464 healthy male Japanese workers

Circulation Journal

Volumn 75, Issue 12, 2011, Pages 2885-2892

  Kondo, Takahisa ^a   Osugi, Shigeki ^a   Shimokata, Keiko ^a   Honjo, Haruo ^b   Morita, Yasuhiro ^a   Maeda, Kengo ^a   Yamashita, Kentaro ^a   Muramatsu, Takashi ^a   Shintani, Satoshi ^a   Matsushita, Kunihiro ^a   Murohara, Toyoaki ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY   (Japan)

Author keywords

Cardiovascular event; Longitudinal cohort study; Mortality; Smoking cessation

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HAZARD RATIO; HEALTH SURVEY; HUMAN; JAPANESE; LEUKOCYTE COUNT; LIFESTYLE MODIFICATION; MALE; NORMAL HUMAN; PROSPECTIVE STUDY; PUBLIC HEALTH PROBLEM; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SMOKING CESSATION; SMOKING HABIT; STROKE; SUBARACHNOID HEMORRHAGE;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CARDIOVASCULAR DISEASES; FOLLOW-UP STUDIES; HUMANS; JAPAN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SMOKING; SMOKING CESSATION;

EID: 82455210504     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-11-0416     Document Type: Article

References (35)

1. World Lung Foundation/the American Cancer Society. The Tobacco Atlas, Third Edition. http://www.tobaccoatlas.org/males.html (accessed July 7, 2011).
2. Kinjo K, Sato H, Shiotani I, Kurotobi T, Ohnishi Y, Hishida E, et al. Circadian variation of the onset of acute myocardial infarction in the Osaka area, 1998-1999: Characterization of morning and nighttime peaks. Jpn Circ J 2001; 65: 617-620.
3. Ueshima H, Choudhury SR, Okayama A, Hayakawa T, Kita Y, Kadowaki T, et al. Cigarette smoking as a risk factor for stroke death in Japan: NIPPON DATA80. Stroke 2004; 35: 1836-1841.
4. Iso H, Date C, Yamamoto A, Toyoshima H, Watanabe Y, Kikuchi S, et al. Smoking cessation and mortality from cardiovascular disease among Japanese men and women: The JACC Study. Am J Epidemiol 2005; 161: 170-179.
5. Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: A case-control study. Lancet 2006; 368: 647-658.
6. Fujiwara H. Smoking is a disease and smokers are patients. Circ J 2010; 74: 628-629.
7. International Agency for Research on Cancer. Tobacco smoking and involuntary smoking. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans, Vol. 83. Lyon, France, IARC, 2004.
8. U.S. Department of Health & Human Services Office of the Surgeon General. The health consequences of smoking: A report of the Surgeon General. Washington, DC: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, May 27, 2004. http://www.surgeongeneral.gov/library/smokingconsequences (accessed July 7, 2011).
9. Wolf PA, D'Agostino RB, Kannel WB, Bonita R, Belanger AJ. Cigarette smoking as a risk factor for stroke: The Framingham Study. JAMA 1988; 259: 1025-1029.
10. Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 937-952.
11. International Agency for Research on Cancer. Reversal of Risk after Quitting Smoking. Vol. 11. IARC Handbooks of Cancer Prevention, Tobacco Control. Lyon, France, IARC, 2007.
12. U.S. Department of Health and Human Services. A Report of the Surgeon General: How Tobacco Smoke Causes Disease: What It Means to You, 2010. http://www.cdc.gov/tobacco/data_statistics/sgr/2010/consumer_booklet/pdfs/consumer.pdf (accessed July 7, 2011).
13. Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990; 80: 954-958.
14. Hozawa A, Ohkubo T, Yamaguchi J, Ugajin T, Koizumi Y, Nishino Y, et al. Cigarette smoking and mortality in Japan: The Miyagi Cohort Study. J Epidemiol 2004; 14: S12-S17.
15. Doll R, Peto R, Boreham J, Sutherland I. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
16. Brunnhuber K, Cummings KM, Feit S, Sherman S, Woodcock J. Putting evidence into practice: Smoking cessation. BMJ Group. 2007.
17. Higashiyama A, Okamura T, Ono Y, Watanabe M, Kokubo Y, Okayama A. Risk of smoking and metabolic syndrome for incidence of cardiovascular disease: Comparison of relative contribution in urban Japanese population: The Suita study. Circ J 2009; 73: 2258-2263.
18. Nakamura K, Huxley R, Ansary-Moghaddam A, Woodward M. The hazards and benefits associated with smoking and smoking cessation in Asia: A meta-analysis of prospective studies. Tob Control 2009; 18: 345-353.
19. Honjo K, Iso H, Tsugane S, Tamakoshi A, Satoh H, Tajima K, et al. The effects of smoking and smoking cessation on mortality from cardiovascular disease among Japanese: Pooled analysis of three large-scale cohort studies in Japan. Tob Control 2010; 19: 50-57.
20. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157-163.
21. World Health Organization. WHO report on the global tobacco epidemic, 2008: The MPOWER package. http://www.who.int/tobacco/mpower/2008/en/index.html (accessed July 7, 2011).
22. Beckman JA, Liao JK, Hurley S, Garrett LA, Chui D, Mitra D, et al. Atorvastatin restores endothelial function in normocholesterolemic smokers independent of changes in low-density lipoprotein. Circ Res 2004; 95: 217-223.
23. Yoshida O, Kondo T, Kureishi-Bando Y, Sugiura T, Maeda K, Okumura K, et al. Pitavastatin, an HMG-CoA reductase inhibitor, ameliorates endothelial function in chronic smokers. Circ J 2010; 74: 195-202.
24. Kubo M, Kiyohara Y, Kato I, Tanizaki Y, Arima H, Tanaka K, et al. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: The Hisayama study. Stroke 2003; 34: 2349-2354.
25. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, et al. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA 2004; 291: 2591-2599.
26. Nakatani D, Sakata Y, Sato H, Mizuno H, Shimizu M, Suna S, et al. Clinical impact of metabolic syndrome and its additive effect with smoking on subsequent cardiac events after acute myocardial infarction. Am J Cardiol 2007; 99: 885-889.
27. Katanoda K, Marugame T, Saika K, Satoh H, Tajima K, Suzuki T, et al. Population attributable fraction of mortality associated with tobacco smoking in Japan: A pooled analysis of three large-scale cohort studies. J Epidemiol 2008; 18: 251-264.
28. Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, et al. Mortality attributable to smoking in China. N Engl J Med 2009; 360: 150-159.
29. Kannel WB. Coronary heart disease risk factors in the elderly. Am J Geriatr Cardiol 2002; 11: 101-107.
30. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R; Prospective Studies Collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 14: 1903-1913.
31. Jacobs DR Jr, Adachi H, Mulder I, Kromhout D, Menotti A, Nissinen A, et al. Cigarette smoking and mortality risk: Twenty-five-year follow-up of the Seven Countries Study. Arch Intern Med 1999; 159: 733-740.
32. Yasue H, Kugiyama K. Coronary spasm: Clinical features and pathogenesis. Intern Med 1997; 36: 760-765.
33. Mannami T, Iso H, Baba S, Sasaki S, Okada K, Konishi M, et al. Cigarette smoking and risk of stroke and its subtypes among middleaged Japanese men and women: The JPHC Study Cohort I. Stroke 2004; 35: 1248-1253.
34. Shinton R, Beevers G. Meta-analysis of relation between cigarette smoking and stroke. BMJ 1989; 298: 789-794.
35. Terres W, Becker P, Rosenberg A. Changes in cardiovascular risk profile during the cessation of smoking. Am J Med 1994; 97: 242-249.